Clinical Trials
90
Active:1
Completed:62
Trial Phases
4 Phases
Phase 1:61
Phase 2:4
Phase 3:16
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (89 trials with phase data)• Click on a phase to view related trials
Phase 1
61 (68.5%)Phase 3
16 (18.0%)Phase 4
8 (9.0%)Phase 2
4 (4.5%)This Study Aims to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties and Food Effect of IN-114199 in Healthy Participants
Phase 1
Not yet recruiting
- Conditions
- Chronic Idiopathic Constipation
- Interventions
- Drug: IN-114199 10mg or placeboDrug: IN-114199 20mg or placeboDrug: IN-114199 2.5mg or placeboDrug: IN-114199 5mg or placeboDrug: IN-114199 40mg or placebo
- First Posted Date
- 2024-12-17
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 80
- Registration Number
- NCT06736912
- Locations
- 🇰🇷
Seoul National University Hospital, Clinical Trial Center, Seoul, Korea, Republic of
To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers
Phase 1
Active, not recruiting
- Conditions
- Non-valvular Atrial Fibrillation (NVAF)
- Interventions
- Drug: IN-G00002
- First Posted Date
- 2024-12-10
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT06725355
- Locations
- 🇰🇷
Central Hospital, Clinical Trial Center, Siheung, Korea, Republic of
Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients
Recruiting
- Conditions
- Adjuvant Chemotherapy
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2024-04-29
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 36
- Registration Number
- NCT06389552
- Locations
- 🇰🇷
Seoul ST. Mary's Hospital, Seoul, Korea, Republic of
PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy Subjects
Phase 1
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 36
- Registration Number
- NCT06332638
- Locations
- 🇰🇷
Inje University Busan Paik Hospital, Busan, Korea, Republic of
Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects
Phase 1
Not yet recruiting
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2023-12-11
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 48
- Registration Number
- NCT06164834
- Locations
- 🇰🇷
Seoul National University Hospital, Clinical Trial Center, Seoul, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- 18
- Next
News
No news found